PT3432912T - Vetores de hsv de elevada transdução - Google Patents
Vetores de hsv de elevada transduçãoInfo
- Publication number
- PT3432912T PT3432912T PT177712650T PT17771265T PT3432912T PT 3432912 T PT3432912 T PT 3432912T PT 177712650 T PT177712650 T PT 177712650T PT 17771265 T PT17771265 T PT 17771265T PT 3432912 T PT3432912 T PT 3432912T
- Authority
- PT
- Portugal
- Prior art keywords
- transducing
- hsv vectors
- hsv
- vectors
- transducing hsv
- Prior art date
Links
- 239000013598 vector Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
- A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16621—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16641—Use of virus, viral particle or viral elements as a vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16641—Use of virus, viral particle or viral elements as a vector
- C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16651—Methods of production or purification of viral material
- C12N2710/16652—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16661—Methods of inactivation or attenuation
- C12N2710/16662—Methods of inactivation or attenuation by genetic engineering
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
- C12N2800/107—Plasmid DNA for vertebrates for mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662313391P | 2016-03-25 | 2016-03-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3432912T true PT3432912T (pt) | 2023-03-02 |
Family
ID=59900838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT177712650T PT3432912T (pt) | 2016-03-25 | 2017-03-24 | Vetores de hsv de elevada transdução |
Country Status (7)
Country | Link |
---|---|
US (2) | US11753653B2 (pt) |
EP (2) | EP4212169A1 (pt) |
CN (2) | CN109362223B (pt) |
DK (1) | DK3432912T3 (pt) |
ES (1) | ES2939644T3 (pt) |
PT (1) | PT3432912T (pt) |
WO (1) | WO2017165813A1 (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK3432912T3 (da) * | 2016-03-25 | 2023-03-13 | Periphagen Inc | Hsv-vektorer med høj transduktion |
US10799560B2 (en) | 2016-03-25 | 2020-10-13 | Periphagen, Inc. | HSV vectors for delivery of NT3 and treatment of CIPN |
PT3377637T (pt) * | 2016-04-08 | 2020-06-17 | Krystal Biotech Inc | Composições para uso em métodos para o tratamento de ferimentos, transtornos e doenças da pele |
US10525090B2 (en) | 2018-04-12 | 2020-01-07 | Krystal Biotech, Inc. | Compositions and methods for the treatment of autosomal recessive congenital ichthyosis |
BR112020021804A2 (pt) | 2018-04-27 | 2021-02-23 | Krystal Biotech, Inc. | genoma de herpes vírus recombinante, vírus herpes, composição, uso do vírus herpes, métodos para intensificar, aumentar, ampliar e/ou suplementar os níveis de uma ou mais proteínas da matriz extracelular dérmica, de uma ou mais proteínas de colágeno, o tecido mole de um sujeito, para melhorar a condição, qualidade e/ou aparência da pele, para reduzir o aparecimento de uma ou mais depressões superficiais na pele, para aumentar e/ou melhorar pelo menos um de textura, suavidade, elasticidade ou tensão da pele e para diminuir um ou mais sinais dermatológicos de envelhecimento |
AU2019346549A1 (en) | 2018-09-24 | 2021-04-15 | Krystal Biotech, Inc. | Compositions and methods for the treatment of netherton syndrome |
JP2022519734A (ja) | 2019-02-08 | 2022-03-24 | クリスタル バイオテック インコーポレイテッド | Cftrポリペプチドを送達するための組成物及び方法 |
CN111440790A (zh) * | 2020-05-08 | 2020-07-24 | 公安部物证鉴定中心 | 唾液斑迹dna和rna同时提取的方法 |
KR20230166118A (ko) | 2021-04-02 | 2023-12-06 | 크리스탈 바이오테크, 인크. | 암 요법을 위한 바이러스 벡터 |
WO2023205661A2 (en) * | 2022-04-18 | 2023-10-26 | Candel Therapeutics, Inc. | Compositions and methods for viral vectors |
WO2023211425A1 (en) * | 2022-04-26 | 2023-11-02 | Periphagen, Inc. | Hsv vectors |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5849571A (en) | 1990-10-10 | 1998-12-15 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Latency active herpes virus promoters and their use |
US5879934A (en) * | 1992-07-31 | 1999-03-09 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Herpes simplex virus strains for gene transfer |
US5804413A (en) | 1992-07-31 | 1998-09-08 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Herpes simplex virus strains for gene transfer |
US5763217A (en) | 1993-11-10 | 1998-06-09 | University Of British Columbia | Method of using, process of preparing and composition comprising recombinant herpesvirus vectors |
US6261552B1 (en) | 1997-05-22 | 2001-07-17 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Herpes simplex virus vectors |
US6774119B1 (en) * | 1999-04-26 | 2004-08-10 | Cedars-Sinai Medical Center | Herpes simplex virus type 1 (hsv-1)-derived vector for selectively inhibiting malignant cells and methods for its use to treat cancers and to express desired traits in malignant and non-malignant mammalian cells |
WO2001053506A2 (en) | 2000-01-21 | 2001-07-26 | Biovex Limited | Virus strains for the oncolytic treatment of cancer |
JP2006503808A (ja) | 2002-06-14 | 2006-02-02 | イエダ リサーチ アンド デベロップメント カンパニー リミテッド | 神経保護及び神経再生用の抗原提示細胞 |
US20030237104A1 (en) * | 2002-06-24 | 2003-12-25 | Tatsuji Nomura | Methods for developing animal models |
US7275561B2 (en) | 2003-10-31 | 2007-10-02 | Lg Electronics Inc. | Discharging valve assembly of reciprocating compressor |
GB0406389D0 (en) * | 2004-03-22 | 2004-04-21 | Istituto Superiore Di Sanito | Recombinant herpes simplex virus and uses therefor |
PT2150218T (pt) * | 2007-05-11 | 2016-08-30 | Convatec Technologies Inc | Aparelho de ostomia |
US20080289058A1 (en) | 2007-05-14 | 2008-11-20 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Targeted delivery of glycine receptors to excitable cells |
WO2013109604A1 (en) * | 2012-01-19 | 2013-07-25 | Alnylam Pharmaceuticals, Inc. | Viral attenuation and vaccine production |
CN103667175A (zh) | 2013-11-17 | 2014-03-26 | 山东省眼科研究所 | 一种单疱病毒潜伏感染细胞模型的建立及活化方法 |
US10799560B2 (en) * | 2016-03-25 | 2020-10-13 | Periphagen, Inc. | HSV vectors for delivery of NT3 and treatment of CIPN |
DK3432912T3 (da) | 2016-03-25 | 2023-03-13 | Periphagen Inc | Hsv-vektorer med høj transduktion |
-
2017
- 2017-03-24 DK DK17771265.0T patent/DK3432912T3/da active
- 2017-03-24 WO PCT/US2017/024092 patent/WO2017165813A1/en active Application Filing
- 2017-03-24 CN CN201780019426.3A patent/CN109362223B/zh active Active
- 2017-03-24 CN CN202310991291.4A patent/CN117143837A/zh active Pending
- 2017-03-24 PT PT177712650T patent/PT3432912T/pt unknown
- 2017-03-24 ES ES17771265T patent/ES2939644T3/es active Active
- 2017-03-24 EP EP22212491.9A patent/EP4212169A1/en not_active Withdrawn
- 2017-03-24 US US16/088,393 patent/US11753653B2/en active Active
- 2017-03-24 EP EP17771265.0A patent/EP3432912B1/en active Active
-
2023
- 2023-07-26 US US18/359,013 patent/US20240158809A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20200199618A1 (en) | 2020-06-25 |
US11753653B2 (en) | 2023-09-12 |
EP3432912A1 (en) | 2019-01-30 |
ES2939644T3 (es) | 2023-04-25 |
US20240158809A1 (en) | 2024-05-16 |
CN109362223A (zh) | 2019-02-19 |
DK3432912T3 (da) | 2023-03-13 |
CN109362223B (zh) | 2023-08-25 |
EP3432912A4 (en) | 2019-09-18 |
EP3432912B1 (en) | 2022-12-21 |
CN117143837A (zh) | 2023-12-01 |
WO2017165813A1 (en) | 2017-09-28 |
EP4212169A1 (en) | 2023-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2549809C (en) | Vector | |
AU201616678S (en) | Cylindres | |
PT3432912T (pt) | Vetores de hsv de elevada transdução | |
GB201403684D0 (en) | Vector | |
GB201614093D0 (en) | Vector | |
GB201509578D0 (en) | Vectors | |
GB201715052D0 (en) | Vectors | |
GB201607534D0 (en) | Peptides | |
GB201717524D0 (en) | Vectors | |
AU201617244S (en) | Case | |
GB201604468D0 (en) | Peptides | |
GB201509881D0 (en) | Complementary vectors | |
GB201705927D0 (en) | Vector | |
GB201612150D0 (en) | Modified peptide | |
GB201607535D0 (en) | Peptides | |
IL274278A (en) | vectors | |
GB2553488B (en) | Luggage | |
GB201619778D0 (en) | Polytunnel arrangement | |
GB201614916D0 (en) | wetsuit | |
GB2545036B (en) | Luggage | |
GB201711971D0 (en) | Vectors | |
GB201608163D0 (en) | Vector | |
GB201609978D0 (en) | Expression vector | |
GB201612665D0 (en) | Peptides | |
GB201621210D0 (en) | Polytunnel arrangement |